But instead she can now add some shadily-timed trading of Mylan stock to her growing list of “Things That Suck For Me Right Now.” Heather Bresch, the CEO at the center of EpiPen’s 471% price hike, sold 100,200 of her shares earlier this …
Stringer, who manages the city’s five pension funds that own more than a million shares of Mylan stock worth $45 million, sent a letter to the company demanding corporate governance reform to boost oversight and accountability. The five city …
What a difference a hostile takeover bid can make. Perrigo Co. for months has been publicly trashing Mylan NV and its prospects as part of an effort to fend off a roughly $27 billion hostile bid from the Dutch company. But the concerns …
PITTSBURGH – Generic drug maker Mylan Laboratories Inc. (MYL) is buying branded drug maker King Pharmaceuticals Inc. (KG) for about $4 billion in stock, company officials said Monday. Mylan has pursued a stronger position in the …
NEW YORK – Shares of Mylan NV slumped 5% in premarket trade Monday, after the drug maker said it began a public offering of 35 million shares of its common stock held by Abbott Laboratories . That represents 32% of the 110 million …
Perrigo's board of directors rejected an April 6 unsolicited bid of $28.9 billion in cash and stock by Mylan, as well as a subsequent deal valued at about $31.3 billion. Perrigo has about 12,500 workers worldwide, with the majority of its …
But the program also prohibited schools from buying competitors’ devices — a provision that experts say may have violated antitrust law ... Mylan). As of July 2016, all other states — except Hawaii — allow, but don’t require, …
PBS1y
Mylan's shares dropped after it said that delays in launching key new drugs and lower prices for generics in the United States will hurt its profitability this and next year. Fred Katayama reports. Mylan's stock plunged after the maker of Epi …
First, CEO Bresch may have engaged in insider trading when she sold over 100,000 shares of Mylan stock in advance of the latest price increases. As noted in the second link above, the stock price fell drastically after Dr. Rogers' piece was …
Shareholders of the drugmaker Perrigo have shut the door on a $26-billion hostile takeover bid from Mylan. Mylan said that its cash-and-stock offer failed to garner enough interest from Perrigo shareholders by a Friday morning deadline to …